Drug Development

Jul 12, 2017
By Pharmaceutical Technology Editors
New study shows that an antimicrobial peptide packaged in a silicon nanoparticle significantly reduced bacteria load in the lungs of mice infected with Pseudomonas aeruginosa.
Jul 11, 2017
By Pharmaceutical Technology Editors
In an FDAVoice blog post, the CDER director highlighted two recent scientific advances.
Jul 10, 2017
By Pharmaceutical Technology Editors
The National Institutes of Health says a new study showed that hydroxychloroquine reduced the transmission of Zika in pregnant mice.
Jul 05, 2017
By Pharmaceutical Technology Editors
ADV7103 is being evaluated in a Phase III trial in Europe in children and adults with distal renal tubulopathy acidosis. Results from the study are expected in the coming months.
Jul 05, 2017
By Pharmaceutical Technology Editors
Partners will use an AI-enabled platform to discover new small molecules across different therapeutic areas.
Jul 05, 2017
By Pharmaceutical Technology Editors
SOBI003 is a chemically modified variant of a recombinant human sulfamidase product candidate, using Sobi’s proprietary glycan modification technology.
Jul 03, 2017
By Pharmaceutical Technology Editors
The collaboration will focus on the discovery, development, and commercialization of novel therapeutics targeting an undisclosed G protein-coupled receptor (GPCR) that plays an important role in inflammatory diseases.
Jul 02, 2017
Pharmaceutical Technology
Pharma’s test of continuous manufacturing is starting with oral solid-dosage forms.
Jul 02, 2017
Pharmaceutical Technology
The more pharma science and technology change, the more business and policy concerns stay the same.
Jul 02, 2017
Pharmaceutical Technology
Industrial-scale continuous API manufacturing may offer cost and safety benefits.
native1_300x100
lorem ipsum